Publications by authors named "Joelle Guilhot"

71Publications

Plasma proteomics of biomarkers for inflammation or cancer cannot predict relapse in chronic myeloid leukaemia patients stopping tyrosine kinase inhibitor therapy.

Leuk Res 2020 03 23;90:106310. Epub 2020 Jan 23.

Department of Medical Sciences, Uppsala University, Uppsala, Sweden; Section of Hematology, Uppsala University Hospital, Uppsala, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2020.106310DOI Listing
March 2020

Model-Based Inference and Classification of Immunologic Control Mechanisms from TKI Cessation and Dose Reduction in Patients with CML.

Cancer Res 2020 06 10;80(11):2394-2406. Epub 2020 Feb 10.

Institute for Medical Informatics and Biometry, Carl Gustav Carus Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-19-2175DOI Listing
June 2020

Favourable outcome of de novo advanced phases of childhood chronic myeloid leukaemia.

Eur J Cancer 2019 07 10;115:17-23. Epub 2019 May 10.

Medical Faculty, Department of Pediatric Hematology and Oncology, Technical University, Dresden, Germany.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09598049193022
Publisher Site
http://dx.doi.org/10.1016/j.ejca.2019.03.020DOI Listing
July 2019

Superoxide dismutase 2 (SOD2) contributes to genetic stability of native and T315I-mutated BCR-ABL expressing leukemic cells.

Biochem Biophys Res Commun 2018 04 17;498(4):715-722. Epub 2018 Mar 17.

INSERM U935, Poitiers, Université de Poitiers, France; INSERM U935 Université Paris Sud & Service d'Hématologie, Institur Federatif d'Hématologie IFHIPS, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbrc.2018.03.023DOI Listing
April 2018

Tri-methylation of H3K79 is decreased in TGF-β1-induced epithelial-to-mesenchymal transition in lung cancer.

Clin Epigenetics 2017 8;9:80. Epub 2017 Aug 8.

Laboratoire Ecologie et Biologie des Interactions (EBI), Université de Poitiers, UMR-CNRS 7267, F-86073 Poitiers, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13148-017-0380-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549304PMC
April 2018

Long-Term Follow-Up of the French Stop Imatinib (STIM1) Study in Patients With Chronic Myeloid Leukemia.

J Clin Oncol 2017 Jan 31;35(3):298-305. Epub 2016 Oct 31.

Gabriel Etienne and François-Xavier Mahon, Institut Bergonié, Bordeaux; Joëlle Guilhot and François Guilhot, Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Universitaire (CHU) de Poitiers, Poitiers; Delphine Rea, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris (AP-HP); Bruno Varet, Hôpital Necker, AP-HP et Université Paris Descartes, Paris; Françoise Rigal-Huguet, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse; Franck Nicolini, Centre Hospitalier Lyon Sud, Pierre Bénite; Aude Charbonnier, Institut Paoli Calmette, Marseille; Agnès Guerci-Bresler, CHU Brabois Vandoeuvre, Nancy; Laurence Legros, Hôpital de l'Archet, Centre Hospitalier Universitaire de Nice, Nice; Martine Gardembas, CHU d'Angers, Angers; Viviane Dubruille, CHU Hôtel-Dieu, Nantes; Michel Tulliez, Hôpital Henri Mondor, Créteil; Marie-Pierre Noel, Hôpital Claude Huriez, Centre Hospitalier Regional Universitaire de Lille, Lille; Jean-Christophe Ianotto, CHU Morvan, Brest; Bruno Villemagne, Centre Hospitalier Départemental La Roche-Sur-Yon, La Roche-Sur-Yon; Martin Carré, Hôpital Albert Michallon, CHU de Grenoble, Grenoble; Philippe Rousselot, Hôpital André Mignot, Le Chesnay; and François-Xavier Mahon, CHU de Bordeaux, INSERM U1218, Bordeaux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.68.2914DOI Listing
January 2017

Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States.

J Natl Cancer Inst 2016 Jul 4;108(7). Epub 2016 Mar 4.

Affiliations of authors:Department of Health Policy and Management, Johns Hopkins University , Baltimore, MD (WVP); Department of Medicine (RAL) and Departments of Pediatrics and of Public Health Sciences (RMC), University of Chicago, Chicago, IL; Eshelman School of Pharmacy and Gillings School of Global Public Health, Lineberger Comprehensive Cancer Center , and Cecil G. Sheps Center for Health Services Research, University of North Carolina , Chapel Hill, NC (SBD); Department of Haematology, Hammersmith Hospital, Imperial College , London , UK (JFA); Department of Medicine (RH, SS) and Department of Hematology and Oncology (MCM), University of Heidelberg, Mannheim, Germany; Department of Haematology and Oncology, S. Orsola-Malpighi University Hospital (MB), and Department of Hematology, "L. e A. Seragnoli" (GM), University of Bologna , Bologna , Italy ; Department of Haematology and Oncology, University Hospital , Jena , Germany (EE); INSERM Centre d'Investigation Clinique (CIC) 1402, CHU de Poitiers, Poitiers, France (JG, FG); Laboratoire d'Hematologie, Universite Victor Segalen, Bordeaux, Pessac, France (FXM); Department of Internal Medicine, Hematology and Oncology, University Hospital Brno , Brno , Czech Republic (JM); Department of Hematology and Oncology, University Hospital Leipzig , Leipzig , Germany (DN); Barbara Ann Karmanos Cancer Institute, Wayne State University , Detroit, MI (CAS); Department of Medicine, Weill Cornell Medical Center , New York, NY (RTS); Uppsala University , Uppsala , Sweden (BS).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djw003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4948567PMC
July 2016

Cultural adaptation of the female pelvic floor questionnaire (FPFQ) into French.

Neurourol Urodyn 2017 02 20;36(2):253-258. Epub 2015 Nov 20.

Université de Poitiers, Faculté de Médecine et Pharmacie, CHU de Poitiers, Poitiers, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/nau.22932DOI Listing
February 2017

Preventing Urinary Incontinence With Supervised Prenatal Pelvic Floor Exercises: A Randomized Controlled Trial.

Obstet Gynecol 2015 Aug;126(2):370-7

Université de Poitiers, INSERM CIC1402, CHU de Poitiers, Poitiers, France; INSERM U1018, INED, and Université ParisSud-11, CHU Bicêtre APHP, Kremlin-Bicêtre, Université de Montpellier-1, CHU Carémeau, Nîmes, Hôpital intercommunal de Poissy-Saint-Germain-en-Laye, Poissy, Centre Hospitalier d'Arcachon, Arcachon, Université de la Réunion, CHU de Saint-Denis, Saint-Denis-de-la-Réunion, Université ParisSud-11, CHU Antoine-Béclère APHP, Clamart, Montreuil, and Université Versailles-St-Quentin, Research Unit EA 7285, Montigny-le-Bretonneux, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/AOG.0000000000000972DOI Listing
August 2015

Analyzing molecular response in chronic myeloid leukemia clinical trials: pitfalls and golden rules.

Cancer 2015 Feb 24;121(4):490-7. Epub 2014 Oct 24.

INSERM Clinical Investigation Center 1402, Poitiers University, Poitiers, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29053DOI Listing
February 2015

Loss of major molecular response as a trigger for restarting tyrosine kinase inhibitor therapy in patients with chronic-phase chronic myelogenous leukemia who have stopped imatinib after durable undetectable disease.

J Clin Oncol 2014 Feb 9;32(5):424-30. Epub 2013 Dec 9.

Philippe Rousselot, Hôpital Mignot, Université Versailles Saint-Quentin-en-Yvelines, Versailles; Aude Charbonnier, Institut Paoli Calmette, Marseille; Pascale Cony-Makhoul, Hôpital d'Annecy, Pringy; Philippe Agape, Hôpital Felix Guyon-Centre Hospitalier Universitaire en France (CHU) de la Réunion, La Réunion; Franck E. Nicolini, Centre Hospitalier Lyon Sud, Pierre-Bénite; Bruno Varet, Hôpital Necker, Assistance Publique-Hopitaux de Paris (AP-HP) et Université Paris Descartes; Delphine Réa and Jean Michel Cayuela, Hôpital Saint-Louis, AP-HP, Paris; Martine Gardembas, CHU d'Angers, Angers; Gabriel Etienne and Josy Reiffers, Institut Bergonié; François-Xavier Mahon, Hôpital Haut-Levèque et Université Bordeaux Ségalen, Bordeaux; Lydia Roy, Joëlle Guilhot, and François Guilhot, Institut National de la Santé et de la Recherche Médicale (INSERM) Centres d'Investigation Clinique CHU de Poitiers, Poitiers; Martine Escoffre-Barbe, Centre Hospitalier Pontchaillou, Rennes; Agnès Guerci-Bresler, CHU Brabois Vandoeuvre, Nancy; Michel Tulliez, Hôpital Henri Mondor, AP-HP, Créteil; Stéphane Prost, Commissariat à l'Énergie Atomique et aux Énergies Alternatives, Institute of Emerging Diseases and Innovative Therapies, Fontenay-aux-Roses; Marc Spentchian, Hôpital Mignot, Le Chesnay; and Jean Claude Chomel and Ali Turhan, INSERM U935, Université Poitiers et Paris Sud, Le Kremlin Bicêtre, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.48.5797DOI Listing
February 2014

Global Decrease of Histone H3K27 Acetylation in ZEB1-Induced Epithelial to Mesenchymal Transition in Lung Cancer Cells.

Cancers (Basel) 2013 Apr 3;5(2):334-56. Epub 2013 Apr 3.

Department of Medicine, Hematology Oncology Division, MUSC, 96 Jonathan Lucas St., Charleston, SC 29425, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers5020334DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730320PMC
April 2013

Comparison of PET-CT and magnetic resonance diffusion weighted imaging with body suppression (DWIBS) for initial staging of malignant lymphomas.

Eur J Radiol 2013 Nov 9;82(11):2011-7. Epub 2013 Aug 9.

Department of Radiology, CHU de Poitiers, rue de la milétrie, 86000 Poitiers, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejrad.2013.05.042DOI Listing
November 2013

The presence of sodium nitrate in generator eluate decreases the radiochemical purity of 99mTc-sestamibi.

J Nucl Med Technol 2012 Sep 7;40(3):187-93. Epub 2012 Aug 7.

Department of Nuclear Medicine and Radiopharmacy, University Hospital, Poitiers, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnmt.111.101246DOI Listing
September 2012

Selection pressure exerted by imatinib therapy leads to disparate outcomes of imatinib discontinuation trials.

Haematologica 2012 Oct 14;97(10):1553-61. Epub 2012 Mar 14.

Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://www.haematologica.org/cgi/doi/10.3324/haematol.2012.0
Publisher Site
http://dx.doi.org/10.3324/haematol.2012.062844DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3487556PMC
October 2012

Curing chronic myeloid leukemia.

Curr Hematol Malig Rep 2012 Jun;7(2):103-8

Service des Maladies du Sang et EA3518, Hôpital Saint-Louis, AP-HP, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-012-0117-2DOI Listing
June 2012

Predicting response in CML.

Blood 2011 Feb;117(6):1773-4

CIC 802 INSERM.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2010-11-317123DOI Listing
February 2011

Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemia.

Haematologica 2010 Aug 11;95(8):1325-33. Epub 2010 May 11.

Gene and Stem Cell Therapy Program, Centenary Institute, Locked Bag No 6, Newtown, NSW 2042, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2009.020636DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2913081PMC
August 2010

A pair analysis of the delayed graft function in kidney recipient: the critical role of the donor.

J Crit Care 2010 Dec 8;25(4):582-90. Epub 2010 Apr 8.

INSERM Unité 927 CHU Poitiers, 86021 Poitiers, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcrc.2010.02.011DOI Listing
December 2010

Interferon in chronic myeloid leukaemia: past and future.

Best Pract Res Clin Haematol 2009 Sep;22(3):315-29

INSERM CIC 0802 and Department of Oncology-Haematology and Cell Therapy, CHU de Poitiers, 2 Rue de la Milétrie, 86021 POITIERS CEDEX, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2009.10.005DOI Listing
September 2009

Neutrophil gelatinase-associated lipocalin expression in chronic myeloid leukemia.

Leuk Lymphoma 2008 May;49(5):984-8

Service d'Hématologie et Oncologie Biologique - EA 3805, CHU de Poitiers, Université de Poitiers, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190801942360DOI Listing
May 2008

Immunotherapeutic approaches in chronic myelogenous leukemia.

Leuk Lymphoma 2008 Apr;49(4):629-34

Department of Oncology-Haematology and Cell Therapy, EA 3805 and Clinical Research Centre, CHU de Poitiers, Poitiers, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190801927510DOI Listing
April 2008

Immunotherapy in chronic myelogenous leukemia.

Clin Lymphoma Myeloma 2007 Mar;7 Suppl 2:S64-70

Department of Oncology-Hematology and Cell Therapy, Clinical Research Centre, Centre Hospitalier Universitaire de Poitiers, France. e-mail:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/clm.2007.s.004DOI Listing
March 2007

Oral glutamine and amino acid supplementation inhibit whole-body protein degradation in children with Duchenne muscular dystrophy.

Am J Clin Nutr 2006 Apr;83(4):823-8

Centre d'Investigation Clinique 9202 INSERM, Assistance Publique-Hôpitaux de Paris, Hôpital Robert Debré, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ajcn/83.4.823DOI Listing
April 2006

Interferon therapy in chronic myelogenous leukemia.

Hematol Oncol Clin North Am 2004 Jun;18(3):585-603, viii

Department of Oncology-Hematology and Cell Therapy, CHU La Milétrie, 2 Rue de la Milètrie, 86021 Poitiers, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2004.03.002DOI Listing
June 2004

Expression and activity of g protein-coupled receptor kinases in differentiated thyroid carcinoma.

J Clin Endocrinol Metab 2002 Jul;87(7):3279-86

Biophysics Laboratory, Department of Pathology, Jean Bernard Hospital, BP 577, 86021 Poitiers Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jcem.87.7.8618DOI Listing
July 2002